Immunology/Inflammation

The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-   C3283 2-Trifluoromethyl-2'-methoxychalconeSummary: Nrf2 activator C3283 2-Trifluoromethyl-2'-methoxychalconeSummary: Nrf2 activator
-   C4158 (R)-LisofyllineSummary: anti-inflammatory agent C4158 (R)-LisofyllineSummary: anti-inflammatory agent
-   B2133 SuprofenTarget: COXSummary: dual COX-1/COX-2 inhibitor B2133 SuprofenTarget: COXSummary: dual COX-1/COX-2 inhibitor
-   B5447 BAY-X 1005Summary: Potent FLAP inhibitor B5447 BAY-X 1005Summary: Potent FLAP inhibitor
-   C7120 3,4-Dimethoxycinnamic acid C7120 3,4-Dimethoxycinnamic acid
-   C7195 Propyphenazone (4-Isopropylantipyrine) C7195 Propyphenazone (4-Isopropylantipyrine)
-   A3311 CID-2858522Summary: NF-κB pathway inhibitor A3311 CID-2858522Summary: NF-κB pathway inhibitor
-   A8526 Strontium RanelateSummary: Calcium Channel activator A8526 Strontium RanelateSummary: Calcium Channel activator
-   C4126 Bradykinin (acetate)Summary: inflammatory mediator C4126 Bradykinin (acetate)Summary: inflammatory mediator
-   B1187 Imiquimod maleateSummary: Immune response modifier B1187 Imiquimod maleateSummary: Immune response modifier
